Analytical characteristics of phytoalexin resveratrol

  • V.Y. Mamchur -
  • N.A. Marchon -
Keywords: resveratrol, phytoalexin, stilbene, UV spectrophotometry, chromatography

Abstract

Search of plants with a sufficient source of raw materials, complex use of raw materials for the purpose of creation of new medicines explains interest to studying of plants with a certain range of properties. The set of the unified techniques of the analysis is necessary for development of a package of standard documentation on created medicinal forms of resveratrol and biologically active additives with it.

References

1. Kishkovsky ZN, Skurikhin I.M. Chemistry of wine. - M: Food industry. - 1976 - 312 pp.
2. Aggarwal B. B., Bhardwaj A., Aggarwal R. S. et al. Role of resveratrol in the prevention and treatment of cancer: preclinical and clinical studies. // anticancer Res - 2004. - V. 24, N 5A. - P. 2783-2840.
3. Barlass M., Miller R. M. Development of methods for screening grapevines for resistance to infection by downy mildew. // Am. J. Enol. Vitic - 1987. - V. 38 (1). - P. 65-68
4. Birzas Nevadas J. J., Contento Salcedo A. M., Castaneda Penalvo G. // Analyst. - 1999. - P. 124. - P. 61-66.
5. Blache, D., I.Rustan, P.Durand. 1997. J. Chromatogr. B 702: 103-110
6. Callemien D., Jerkovic V., Rozenberg R., Collin S. Hop. As an interesting source of resveratrol for brewers, tandem mass spectrometry is used for optimization of the extraction and quantitative study by liquid chromatography. - Mr Agric. Food Chem. - 2005, Jan. - vol. 53, N 2. - P. 424-429.
7. Cao Y., Zhang M., Yu H. et al. Effects of meteorological factors and mineral elements on the content of resveratrol in Polygonum cuspidatum rootstalk. - Ying Yong Sheng Tai Xue Bao. - 2004, Jul. - vol. 15, N 7. - P. 1143-1147.
8. Careri M., Corradini C., Elviri L. et al. Liquid chromatography-electrospray tandem mass spectrometry of cis-resveratrol and trans-resveratrol: development, validation, and application of the method to red wine, grape, and winemaking by-products. - Mr Agric. Food Chem. - 2004, Nov. - vol. 52, N 23. - P. 6868-6874.
9. Cardile V., Lombardo L., Spatafor C., Tringal C. Chemo-enzymatic synthesis and cell-growth inhibition activity of resveratrol analogues. - Bioorg. Chem - 2005 - Vol. 33, N 1.- P. 22-33.
10. De Medina P., Casper R., Savouret J.F., Poirot M. Synthesis and biological properties of new stilbenes derivatives of resveratrol as new selective aryl hydrocarbon modulators. - J. Med.Chem. - 2005 - Vol. 48, N 1 - P. 287-291.
11. Donnelly L.E., Newton R., Kennedy G.E. et al Anti-inflammatory effects of resveratrol in lung epithelial cells: molecular mechanisms. - Am.J. Physiol Lung Cell Mol Physiol - 2004 - Vol. 287, No. 4 - P. 774-783.
12. Flamini R., Dalla Vedova A. Fast determination of total free resveratrol content in wine by direct-exposure-probe, positive-ion chemical ionization and collision-induced-dissociation mass spectrometry. - Rapid Commun Mass Spectrom. - 2004 - Vol. 18, N 17. - 1925-1931.
13. Flurkey K., Currer M. Pitfalls of animal model systems in aging research. - Best Pract. Res Clin Endocrinol Metab. -2004 - vol. 18, N 3. - P. 407-421.
14. Fulda S., Debatin K.M. Sensitization for an anticancer drug-induced apoptosis by the chemopreventive agent resveratrol. - Oncogene - 2004 - Vol. 23, N 40. - p. 6702-6711.
15. Gamble A., Stroll D., Ugliano M. et al. Trans-Resveratrol, quercetin, catechin, and epicatechin content in the south of the Italian monovarietal wines: the relationship with maceration time and marc pressing during winemaking. - J. Agric.Food. Chem - 2004 Sep .; 8; 52 (18): 5747. 13. Gao S., Feng N., Yu S. et al. Vasodilator consti tuents from the roots of Lysidice rhodostega.-Planta Med. - 2004, Dec .; 70 (12): 1128-34.
16. Giorcelli A., Sparvoli F., Mattivi F. et al. Expression of the stilbene synthase (StSy) gene from grapevine in transgenic white poplar results in high accumulation of the antioxidant resveratrol glucosides. - Transgenic Res - 2004 Jun .; 13 (3): 203-14.
17. Hyun J.Y., Chun Y.S., Kim T.Y. et al Hypoxia-inducible factor 1alpha-mediated resistance to phenolic anticancer. Chemotherapy - 2005 Jun .; 50 (3): 119-26.
18. Ito T., Furusawa M., Tanaka T., Ali Z. et al. Resveratrol Derivatives from Upuna borneensis.-Chem. Pharm Bull (Tokyo). - Feb. 2005; 53 (2): 219-24.
19. Kerem Z., Bravdo B. A., Shoseyov O., Tugend haft Y. Rapid liquid chromatography-ultraviolet determination of organic acids and phenolic compounds in red wine and black. - J. Chromatogr A., 2004, Oct .; 15; 1052 (1-2): 211-5.
20. Kim D.H., Kim J.H., Baek S.H. et al Enhancement of tyrosinase inhibition of Veratrum patulum using cellulose extract. - Biotechnol.Bioeng. - 2004 Sep. 30; 87 (7): 849-54.
21. Kiziltepe U., Turan N. N., Han U. et al. Resveratrol, a red wine polyphenol, protects the spinal cord from ischemia-reperfusion injury. J. Vasc. Surg - 2004 Jul .; 40 (1): 138-45.
22. Krishnan V., Zeichner S.L. Host cell gene expression during human immunodeficiency virus type 1 latency and reactivation and the effects of targeting genes that are differentially expressed in viral lactation. - J. Virol. - 2004 Sep .; 78 (17): 9458-73.
23. Lamuela-Raventos, R.M., A.I. Romero-Petez 1997. Resveratrol and piceid levels in wine production and in finishes wines. In: Watkins, T.R., Ed.Wine: Nutritional and Therapeutic Benefits. American Chemical Society, Washington, DC, pp. 56-68
24. Larrosa M., Thomas-Barberan F.A., Espin J.C. The grape and wine of polyphenol piceatannol is a potent inducer of apoptosis in human SK-Mel-28 melanoma cells. - Eur. J. Nutr. -2004, Oct.; 43 (5): 275-84.
25. Lee E.J., Min H.Y., Joo Park H., Nam Han Y., Lee S.K. et al G2 / M cell cycle arrest and induction of apoptosis by a stilbenoid, 3,4,5-trimethoxy-4'-bromo-cis-stilbene, in human lung cancer cells. - Life Sci. - 2004, Oct. 22; 75 (23): 2829-39.
26. Leiro J., Arranz J. A., Support A. et al. In vitro effects of the polyphenols resveratrol, mangiferin and (-) - epigallocatechin-3-gallate on the scuticocidal fish pathogen Philasterides dicentric acid. Dis. Aquat Organ - 2004, May 5; 59 (2): 171-4.
27. Li H.L., Wang A.B., Huang Y. et al. Isorhapontigen, a new resveratrol analog, which reduces cardiac hypertrophy through blocking signaling transduction pathways. - Free Radic. Biol Med. - 2005, Jan. 15; 38 (2): 243-57.
28. Lin, C, and Y.Chen. 2001. On-line identification of trans- and cis-resveratrol by nonaqueous capillary electrophoresis. Electrophoresis 22: 2574-2579
29. Madar Z., Maayan N., Sarit O., Eliraz A. Antioxidants modulate the nitric oxide system and SOD activity and expression in rat epithelial lung cells. - Asia Pac. J. Clin. Nutr - 2004; 13 (Suppl): S.101.
30. Matsuda H., Tewtrakul S., Morikawa T., Yoshikawa M. Anti-allergic activity of stilbenes from Korean rhubarb (Rheum undulatum L.): structure requirements for inhibiting antigen-induced degranulation and their effects on the release of TNF -alpha and IL-4 in RBL-2H3 cells. - Bioorg. Med. Chem - 2004 Sep. 15; 12 (18): 4871-6.
31. McMurtey, K.D. 1997 Resveratrol in wine. In: Watkins, T.R., Ed.Wine: Nutritional and Therapeutic Benefits. American Chemical Society, Washington, DC. pp. 44-55
32. McMurtey, K.D., J.Minn, K.Pobantz. 1994. Analysis of wines for resveratrol using direct injection high-pressure liquid chromatography with electrochemical detection. J.Agric. Food Chem. 42: 2077-2088.
33. Muriy M., Handler N., Erker T. et al. Resveratrol analogues as selective cyclooxygenase-2in-hibitors: synthesis and structure-activity relation. - Bioorg. Med. Chem -2004, Nov. 1; 12 (21): 5571-8.
34. Nikaido Y., Yoshizawa K., Danbara N. et al. Effects of maternal xenoestrogen exposure on development of the reproductive tract and mammary gland in female CD-1 mouse offspring. - Reprod Toxicol -2004, Aug.-Sep .; 18 (6): 803-11.
35. Okasaka M., Takaishi Y., Kogure K. et al. New stilbene derivatives from Calligonum leucocladum. - J. Nat. Prod. - 2004 Jun .; 67 (6): 1044-6.
36. O'Leary K.A., de Pascual-Tereasa S., Needs P.W. et al The effect of flavonoids and vitamin E on cyclooxygenase-2 (COX-2) transcription. - Mutat. Res - 2004, Jul. 13; 551 (1-2): 245-54.
37. Eggs B., Wachowicz B., Bald E., Glowacki R. Protective effects of resveratrol against changes in blood platelets thiols induced by platinum compounds. - J. Physiol. Pharmacol. - 2004 Jun .; 55 (2): 467-76.
38. Piver B., Fer M., Vitrac X. et al. Involvement of cytochrome P450 1A2 in the biotransformation of trans-resveratrol in human liver microsomes. Biochem Pharmacol. - 2004, Aug. 15; 68 (4): 773-82.
39. Quilez A. M., Saenz M.T., Garcia M.D., De la Puerta R. Phytochemical analysis and antiallergic study of Agave intermixta Trel. and Cissus sicyoides L. - J. Pharm. Pharmacol. - 2004 Sep .; 56 (9): 1185-9.
40. Quiney C., Dauzonne D., Kern C. et al. Flavones and polyphenols inhibit the NO pathway during apoptosis of leukemia B-cells. - Leuk - Res. - Aug. 2004; 28 (8): 851-61.
41. Shi T., Liou L.S., Sadhukhan P. et al. The effects of resveratrol on gene expression in a renal cell carcinoma. - Cancer Biol Ther 2004 Sep .; 3 (9): 882-8.
42. Soleas, G.J., J. Yan, and D.M. Goldberg. 2001. Measurement of trans-resveratrol, (+) - catechin, and quercetin in rat and human blood and urine by gas chromatography with mass selective detection. Methods Enzymol. 335: 130-145
43. Storz P., Doppler H., Toker A. Activation loop phosphorylation controls, protein kinase D-dependent activation of nuclear factor kappa B. Mol. Pharmacol. - 2004 Oct .; 66 (4): 870-9.
44. Sun S., Gao Y., Ling X. The combined effects of phenolic compounds and fluconazole on the formation of ergosterol in Candida albicans, determined by high performance liquid chromatography / tandem mass spectrometry. - Anal. Biochem 2005 Jan. 1; 336 (1): 39-45.
45. With J.L., Lin M.T., Hong C. C., C. C. C. et al Resveratrol induces FasL-related apoptosis via Cdc42 activation of the ASK1 / JNK-dependent signaling pathway in human leukemia HL-60 cells. - Carcinogenesis. -2005 Jan; 26 (1): 1-10.
46. Szaefer H., Cichocki M., Brauze D., Baer-Dubowska W. Alteration in phase I and II enzyme activity and polycyclic aromatic hydrocarbon-DNA adduct formation by plant phenolics in mouse epidermis. - Nutr Cancer - 2004; 48 (1): 70-7.
47. Wang S.G., Ma D.Y., Hu C.Q. Two new oligostilbenes from Caragana sinica. - J. Asian. Nat Prod. Res - 2004, Dec .; 6 (4): 241-8.
48. Wang Y., Wang B., Cheng J. et al. FADD-dependent apoptosis induction in Jurkat's leukemia T-cells by the resveratrol analogue, 3,4,5-trihydroxy-trans-stilbene. Biochem Pharmacol. -2005, Jan. 15; 69 (2): 249-54.
49. Wang K.H., Lai Y.H., Chang J.C. et al Germination of peanut kernels to enhance resveratrol biosynthesis and prepare sprouts as a functional vegetable. - Mr Agric. Food Chem. - 2005, Jan. 26; 53 (2): 242-6.
50. Walle T., Hsieh F., DeLegge M.H. et al High absorption but very low bioavailability of oral resveratrol in humans. - Drug Metab. Dispos - 2004, Dec; 32 (12): 1377-82.
51. Wood J.G., Rogina B., Lavu S. et al. The activators mimic caloric restriction and delay aging in metazoans. - Nature. -2004, Aug .; 5; 430 (7000): 686-9.
52. Yang H., Sung S. H., Kim Y.C. Two New Hepatoprotective Stilbene Glycosides from Acer Mono Leaves. - J. Nat. Prod. 2005 Jan .; 68 (1): 101-3.
53. Yao C. S., Lin M., Liu X., Wang Y.H. Stilbene derivatives from Gnetum cleistostachyum. - J.Asian. Nat Prod. Res 2005 Jun .; 7 (2): 131-7.
54. Yu L., Wu S.L., Zhang M., Pan C.E. The effect of resveratrol alone and its combination with cyclosporin A is on the immune function of human peripheral blood T lymphocytes. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. - November 2003; 19 (6): 549-51.
55. Zhu Y.J., Agbayani R., Jackson M.C., Tang C.S., Moore P.H. Expression of the grapevine stilbene synthase gene VST1 in papaya provides resistance to the disease caused by Phytophthora palmivora. - Plantation .- 2004, Dec. 220 (2): 241-50
56. Zomes S.A., Nogueira J.M., Rebel M.J. An amperometric biosensor for polyphenolic compounds in red wine. - Biosens. Bioelectron - 2004, Dec. 15; 20 (6): 1211-6.
Published
2019-03-18
How to Cite
Mamchur, V., & Marchon, N. (2019). Analytical characteristics of phytoalexin resveratrol. Farmatsevtychnyi Zhurnal, (6), 3-10. Retrieved from https://pharmj.org.ua/index.php/journal/article/view/441